Tags

Type your tag names separated by a space and hit enter

Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008.
Emerg Infect Dis. 2009 Nov; 15(11):1791-8.EI

Abstract

We investigated epidemiologic and clinical aspects of rickettsial diseases in 280 international travelers reported to the GeoSentinel surveillance Network during 1996-2008. Of these 280 travelers, 231 (82.5%) had spotted fever (SFG) rickettsiosis, 16 (5.7%) scrub typhus, 11 (3.9%) Q fever, 10 (3.6%) typhus group (TG) rickettsiosis, 7 (2.5%) bartonellosis, 4 (1.4%) indeterminable SFG/TG rickettsiosis, and 1 (0.4%) human granulocytic anaplasmosis. One hundred ninety-seven (87.6%) SFG rickettsiosis cases were acquired in sub-Saharan Africa and were associated with higher age, male gender, travel to southern Africa, late summer season travel, and travel for tourism. More than 90% of patients with rickettsial disease were treated with doxycycline, 43 (15.4%) were hospitalized, and 4 had a complicated course, including 1 fatal case of scrub typhus encephalitis acquired in Thailand.

Authors+Show Affiliations

Department of Infectious Diseases, Oslo University Hospital, Ullevål, NO-0407 Oslo, Norway. mogens.jensenius@ioks.uio.noNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

19891867

Citation

Jensenius, Mogens, et al. "Multicenter GeoSentinel Analysis of Rickettsial Diseases in International Travelers, 1996-2008." Emerging Infectious Diseases, vol. 15, no. 11, 2009, pp. 1791-8.
Jensenius M, Davis X, von Sonnenburg F, et al. Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerging Infect Dis. 2009;15(11):1791-8.
Jensenius, M., Davis, X., von Sonnenburg, F., Schwartz, E., Keystone, J. S., Leder, K., Lopéz-Véléz, R., Caumes, E., Cramer, J. P., Chen, L., & Parola, P. (2009). Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. Emerging Infectious Diseases, 15(11), 1791-8. https://doi.org/10.3201/eid1511.090677
Jensenius M, et al. Multicenter GeoSentinel Analysis of Rickettsial Diseases in International Travelers, 1996-2008. Emerging Infect Dis. 2009;15(11):1791-8. PubMed PMID: 19891867.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008. AU - Jensenius,Mogens, AU - Davis,Xiaohong, AU - von Sonnenburg,Frank, AU - Schwartz,Eli, AU - Keystone,Jay S, AU - Leder,Karin, AU - Lopéz-Véléz,Rogelio, AU - Caumes,Eric, AU - Cramer,Jakob P, AU - Chen,Lin, AU - Parola,Philippe, AU - ,, PY - 2009/11/7/entrez PY - 2009/11/7/pubmed PY - 2010/2/6/medline SP - 1791 EP - 8 JF - Emerging infectious diseases JO - Emerging Infect. Dis. VL - 15 IS - 11 N2 - We investigated epidemiologic and clinical aspects of rickettsial diseases in 280 international travelers reported to the GeoSentinel surveillance Network during 1996-2008. Of these 280 travelers, 231 (82.5%) had spotted fever (SFG) rickettsiosis, 16 (5.7%) scrub typhus, 11 (3.9%) Q fever, 10 (3.6%) typhus group (TG) rickettsiosis, 7 (2.5%) bartonellosis, 4 (1.4%) indeterminable SFG/TG rickettsiosis, and 1 (0.4%) human granulocytic anaplasmosis. One hundred ninety-seven (87.6%) SFG rickettsiosis cases were acquired in sub-Saharan Africa and were associated with higher age, male gender, travel to southern Africa, late summer season travel, and travel for tourism. More than 90% of patients with rickettsial disease were treated with doxycycline, 43 (15.4%) were hospitalized, and 4 had a complicated course, including 1 fatal case of scrub typhus encephalitis acquired in Thailand. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/19891867/full_citation L2 - https://dx.doi.org/10.3201/eid1511.090677 DB - PRIME DP - Unbound Medicine ER -